{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:30:09Z","timestamp":1793374209441,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"High Level-Hospital Program, Health Commission of Guangdong Province","award":["HKUSZH201906001"],"award-info":[{"award-number":["HKUSZH201906001"]}]},{"name":"HaiYa Young Scientist Foundation of Shenzhen University General Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-94505-0","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T23:26:19Z","timestamp":1743549979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["BMI matters: understanding the link between weight and severe psoriasis"],"prefix":"10.1038","volume":"15","author":[{"given":"Huiwei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youkun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5842-8080","authenticated-orcid":false,"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6234-1554","authenticated-orcid":false,"given":"Hongzhong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0867-8864","authenticated-orcid":false,"given":"Xiaoming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"94505_CR1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/jdv.16926","volume":"35","author":"A Nast","year":"2021","unstructured":"Nast, A. et al. Euroguiderm Guideline on the Systemic Treatment of Psoriasis Vulgaris \u2013 Part 2: Specific Clinical and Comorbid Situations. J. Eur. Acad. Dermatol. Venereol. 35, 281\u2013317 (2021).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"94505_CR2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E. & Barker, J. N. W. N. Psoriasis. The Lancet. 397, 1301\u20131315 (2021).","journal-title":"The Lancet."},{"key":"94505_CR3","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.18245","volume":"182","author":"NJ Korman","year":"2020","unstructured":"Korman, N. J. Management of psoriasis as a systemic disease: What is the evidence?. Br. J. Dermatol. 182, 840\u2013848 (2020).","journal-title":"Br. J. Dermatol."},{"key":"94505_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrendo.2017.157","volume":"14","author":"JA Yanovski","year":"2018","unstructured":"Yanovski, J. A. Obesity: Trends in underweight and obesity - scale of the problem. Nat. Rev. Endocrinol. 14, 5\u20136 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"94505_CR5","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(21)00246-1","volume":"9","author":"B Van der Schueren","year":"2021","unstructured":"Van der Schueren, B. et al. Obesity in people living with type 1 diabetes. The Lancet Diabetes Endocrinol. 9, 776\u2013785 (2021).","journal-title":"The Lancet Diabetes Endocrinol."},{"key":"94505_CR6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jamasurg.2016.4610","volume":"152","author":"A Egeberg","year":"2017","unstructured":"Egeberg, A., S\u00f8rensen, J. A., Gislason, G. H., Knop, F. K. & Skov, L. Incidence and prognosis of psoriasis and psoriatic arthritis in patients undergoing bariatric surgery. Jama Surg. 152, 344\u2013349 (2017).","journal-title":"Jama Surg."},{"key":"94505_CR7","doi-asserted-by":"crossref","first-page":"1200555","DOI":"10.3389\/fpubh.2023.1200555","volume":"11","author":"H Chen","year":"2023","unstructured":"Chen, H. et al. Does obesity Kuznets curve exist in developing economies? Evidence from 38 African countries based on heterogeneous panel data analysis on income-level classification. Front. Public Health. 11, 1200555 (2023).","journal-title":"Front. Public Health."},{"key":"94505_CR8","doi-asserted-by":"crossref","unstructured":"Karlsson, T., Hadizadeh, F., Rask Andersen, M., Johansson, \u00c5. & Ek, W. E. Body mass index and the risk of rheumatic disease: Linear and nonlinear mendelian randomization analyses. Arthritis Rheumatol. 75, 2027\u20132035 (2023).","DOI":"10.1002\/art.42613"},{"key":"94505_CR9","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong, A. W. & Read, C. Pathophysiology, clinical presentation, and treatment of psoriasis. Jama. 323, 1945 (2020).","journal-title":"Jama."},{"key":"94505_CR10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/jdv.18044","volume":"36","author":"JJ Wu","year":"2022","unstructured":"Wu, J. J., Kavanaugh, A., Lebwohl, M. G., Gniadecki, R. & Merola, J. F. Psoriasis and metabolic syndrome: Implications for the management and treatment of psoriasis. J. Eur. Acad. Dermatol. Venereol. 36, 797\u2013806 (2022).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"94505_CR11","doi-asserted-by":"crossref","DOI":"10.1038\/nutd.2012.26","volume":"2","author":"AW Armstrong","year":"2012","unstructured":"Armstrong, A. W., Harskamp, C. T. & Armstrong, E. J. The association between psoriasis and obesity: A systematic review and meta-analysis of observational studies. Nutr. Diabetes. 2, e54 (2012).","journal-title":"Nutr. Diabetes."},{"key":"94505_CR12","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3390\/life13101947","volume":"13","author":"D Vata","year":"2023","unstructured":"Vata, D. et al. Update on obesity in psoriasis patients. Life. 13, 1947 (2023).","journal-title":"Life."},{"key":"94505_CR13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002739","volume":"16","author":"A Budu-Aggrey","year":"2019","unstructured":"Budu-Aggrey, A. et al. Evidence of a causal relationship between body mass index and psoriasis: A mendelian randomization study. Plos Med. 16, e1002739 (2019).","journal-title":"Plos Med."},{"key":"94505_CR14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jaad.2022.11.010","volume":"88","author":"CV Chalitsios","year":"2023","unstructured":"Chalitsios, C. V. et al. Investigating modifiable pathways in psoriasis: A mendelian randomization study. J. Am. Acad. Dermatol. 88, 593\u2013601 (2023).","journal-title":"J. Am. Acad. Dermatol."},{"key":"94505_CR15","first-page":"1068","volume":"317","author":"WJ Meurer","year":"2017","unstructured":"Meurer, W. J. & Tolles, J. Logistic regression diagnostics. Jama. 317, 1068 (2017).","journal-title":"Logistic regression diagnostics. Jama."},{"key":"94505_CR16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/sj.ki.5002787","volume":"73","author":"G Tripepi","year":"2008","unstructured":"Tripepi, G., Jager, K. J., Dekker, F. W. & Zoccali, C. Linear and logistic regression analysis. Kidney Int. 73, 806\u2013810 (2008).","journal-title":"Kidney Int."},{"key":"94505_CR17","doi-asserted-by":"crossref","unstructured":"Geale, K. & Schmitt Egenolf, M. Severity of psoriasis: Time to disentangle severity from symptom control. Br. J. Dermatol. 186, 1033-1034 (2022).","DOI":"10.1111\/bjd.21023"},{"key":"94505_CR18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/jdv.12106","volume":"28","author":"PL Mattei","year":"2014","unstructured":"Mattei, P. L., Corey, K. C. & Kimball, A. B. Psoriasis area severity index (Pasi) and the dermatology life quality index (Dlqi): The correlation between disease severity and psychological burden in patients treated with biological therapies. J. Eur. Acad. Dermatol. Venereol. 28, 333\u2013337 (2014).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"94505_CR19","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaad.2021.06.012","volume":"86","author":"A Norden","year":"2022","unstructured":"Norden, A., Rekhtman, S., Strunk, A. & Garg, A. Risk of psoriasis according to body mass index: A retrospective cohort analysis. J. Am. Acad. Dermatol. 86, 1020\u20131026 (2022).","journal-title":"J. Am. Acad. Dermatol."},{"key":"94505_CR20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(21)00798-4","volume":"398","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Body-mass index and obesity in urban and rural China: Findings from consecutive nationally representative surveys during 2004\u201318. The Lancet. 398, 53\u201363 (2021).","journal-title":"The Lancet."},{"key":"94505_CR21","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","volume":"388","author":"E Di Angelantonio","year":"2016","unstructured":"Di Angelantonio, E. et al. Body-Mass index and all-cause mortality: Individual-participant-data meta-analysis of 239 prospective studies in four continents. The Lancet. 388, 776\u2013786 (2016).","journal-title":"The Lancet."},{"key":"94505_CR22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003288","volume":"17","author":"MG Levin","year":"2020","unstructured":"Levin, M. G. et al. Genetics of height and risk of atrial fibrillation: A mendelian randomization study. Plos Med. 17, e1003288 (2020).","journal-title":"Plos Med."},{"key":"94505_CR23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess, S. & Thompson, S. G. Interpreting findings from mendelian randomization using the Mr-Egger method. Eur. J. Epidemiol. 32, 377\u2013389 (2017).","journal-title":"Eur. J. Epidemiol."},{"key":"94505_CR24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey, S. G. & Burgess, S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512\u2013525 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"94505_CR25","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","volume":"80","author":"A Menter","year":"2019","unstructured":"Menter, A. et al. Joint Aad-Npf guidelines of care for the management and treatment of psoriasis with biologics. J. Am. Acad. Dermatol. 80, 1029\u20131072 (2019).","journal-title":"J. Am. Acad. Dermatol."},{"key":"94505_CR26","volume":"13","author":"N Gao","year":"2022","unstructured":"Gao, N. et al. The association between psoriasis and risk of cardiovascular disease: A mendelian randomization analysis. Front. Immunol. 13, 918224 (2022).","journal-title":"Front. Immunol."},{"key":"94505_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-021-02182-3","volume":"20","author":"L Zhang","year":"2022","unstructured":"Zhang, L., Wang, Y., Qiu, L. & Wu, J. Psoriasis and cardiovascular disease risk in European and East Asian populations: Evidence from meta-analysis and mendelian randomization analysis. BMC Med. 20, 1\u2013421 (2022).","journal-title":"BMC Med."},{"key":"94505_CR28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/10408398.2020.1818053","volume":"62","author":"L Barrea","year":"2022","unstructured":"Barrea, L. et al. Very low-calorie ketogenic diet (Vlckd) in patients with psoriasis and obesity: An update for dermatologists and nutritionists. Crit. Rev. Food Sci. Nutr. 62, 398\u2013414 (2022).","journal-title":"Crit. Rev. Food. Sci. Nutr."},{"key":"94505_CR29","doi-asserted-by":"crossref","unstructured":"Barrea, L. et al. Clinical and nutritional management of very-low-calorie ketogenic diet (VLCKD) in patients with psoriasis and obesity: a practical guide for the nutritionist. Crit. Rev. Food Sci. Nutr. 63, 10775-10791 (2023).","DOI":"10.1080\/10408398.2022.2083070"},{"key":"94505_CR30","doi-asserted-by":"crossref","unstructured":"Hagino, T., Onda, M., Saeki, H., Fujimoto, E. & Kanda, N. Predictive factors for responders to deucravacitinib treatment in patients with psoriasis. J. Dermatol. 52, 551-555 (2025).","DOI":"10.1111\/1346-8138.17601"},{"key":"94505_CR31","doi-asserted-by":"crossref","unstructured":"Hagino, T., Saeki, H., Fujimoto, E. & Kanda, N. Effectiveness of long-term bimekizumab treatment and predictive factors for responders in moderate-to-severe psoriasis: A 52-week real-world study. J. Dermatol. 52, 317-328 (2025).","DOI":"10.1111\/1346-8138.17532"},{"key":"94505_CR32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/1346-8138.17186","volume":"51","author":"T Hagino","year":"2024","unstructured":"Hagino, T., Saeki, H., Fujimoto, E. & Kanda, N. Real-world effectiveness and safety of Bimekizumab in Japanese patients with psoriasis: A single-center retrospective study. J. Dermatol. 51, 649\u2013658 (2024).","journal-title":"J. Dermatol."},{"key":"94505_CR33","first-page":"8537","volume":"22","author":"E Zuccotti","year":"2018","unstructured":"Zuccotti, E. et al. Nutritional strategies for psoriasis: Current scientific evidence in clinical trials. Eur. Rev. Med. Pharmacol. Sci. 22, 8537\u20138551 (2018).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"94505_CR34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/1346-8138.14939","volume":"46","author":"JH Han","year":"2019","unstructured":"Han, J. H. et al. Increased risk of psoriasis in subjects with abdominal obesity: A nationwide population-based study. J. Dermatol. 46, 695\u2013701 (2019).","journal-title":"J. Dermatol."},{"key":"94505_CR35","doi-asserted-by":"crossref","unstructured":"Maglio, C., Peltonen, M., Rudin, A. & Carlsson, L. M. S. Bariatric surgery and the incidence of psoriasis and psoriatic arthritis in the swedish obese subjects study. Obesity (Silver Spring, Md.). 25, 2068\u20132073 (2017).","DOI":"10.1002\/oby.21955"},{"key":"94505_CR36","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.immuni.2023.06.021","volume":"56","author":"P Sivasami","year":"2023","unstructured":"Sivasami, P. et al. Obesity-induced dysregulation of skin-resident Ppar\u03b3 (+) Treg cells promotes Il-17a-mediated psoriatic inflammation. Immunity. 56, 1844\u20131861 (2023).","journal-title":"Immunity."},{"key":"94505_CR37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev-physiol-042222-024353","volume":"86","author":"D Bradley","year":"2024","unstructured":"Bradley, D., Deng, T., Shantaram, D. & Hsueh, W. A. Orchestration of the adipose tissue immune landscape by adipocytes. Annu. Rev. Physiol. 86, 199\u2013223 (2024).","journal-title":"Annu. Rev. Physiol."},{"key":"94505_CR38","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/jdv.18689","volume":"37","author":"U Mrowietz","year":"2023","unstructured":"Mrowietz, U. et al. Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the embrace randomized trial. J. Eur. Acad. Dermatol. Venereol. Jeadv. 37, 348\u2013355 (2023).","journal-title":"J. Eur. Acad. Dermatol. Venereol. Jeadv."},{"key":"94505_CR39","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3389\/fimmu.2019.01507","volume":"10","author":"Y Wong","year":"2019","unstructured":"Wong, Y., Nakamizo, S., Tan, K. J. & Kabashima, K. An update on the role of adipose tissues in psoriasis. Front. Immunol. 10, 1507 (2019).","journal-title":"Front. Immunol."},{"key":"94505_CR40","doi-asserted-by":"crossref","unstructured":"Park, S. H. et al. Impact of Obesity on the Il-6 Immune Marker and Th17 Immune Cells in C57Bl\/6 Mice Models with Imiquimod-Induced Psoriasis. Int. J. Mol. Sci. 24, 5592 (2023).","DOI":"10.3390\/ijms24065592"},{"key":"94505_CR41","doi-asserted-by":"crossref","unstructured":"Sivasami, P. et al. Obesity-induced dysregulation of skin-resident Ppar\u03b3 + Treg cells promotes Il-17a-mediated psoriatic inflammation. Immunity (Cambridge, Mass.). 56, 1844\u20131861 (2023).","DOI":"10.1016\/j.immuni.2023.06.021"},{"key":"94505_CR42","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jid.2020.01.020","volume":"140","author":"Z Shi","year":"2020","unstructured":"Shi, Z. et al. Short-term exposure to a western diet induces psoriasiform dermatitis by promoting accumulation of Il-17a\u2013producing \u0393\u03b4 T cells. J. Invest. Dermatol. 140, 1815\u20131823 (2020).","journal-title":"J. Invest. Dermatol."},{"key":"94505_CR43","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2340\/00015555-3327","volume":"99","author":"MN Goolam","year":"2019","unstructured":"Goolam, M. N. et al. Relationship of visceral fat and adipokines with cardiometabolic diseases in psoriasis. Acta. Derm. Venereol. 99, 1218\u20131223 (2019).","journal-title":"Acta. Derm. Venereol."},{"key":"94505_CR44","volume":"68","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Bcat2-mediated branched-chain amino acid catabolism is linked to the aggravated inflammation in obese with psoriasis mice. Mol. Nutr. Food Res. 68, e2300720 (2024).","journal-title":"Mol. Nutr. Food Res."},{"key":"94505_CR45","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1080\/1744666X.2016.1201423","volume":"12","author":"A Chiricozzi","year":"2016","unstructured":"Chiricozzi, A. et al. Crosstalk between skin inflammation and adipose tissue-derived products: Pathogenic evidence linking psoriasis to increased adiposity. Expert Rev. Clin. Immunol. 12, 1299\u20131308 (2016).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"94505_CR46","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"W Boehncke","year":"2015","unstructured":"Boehncke, W. & Sch\u00f6n, M. P. Psoriasis. Lancet (London, England). 386, 983\u2013994 (2015).","journal-title":"Lancet (London, England)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94505-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94505-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94505-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T09:43:19Z","timestamp":1743759799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94505-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94505"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94505-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Reviewed and approved by HKU-SZH Medical Ethics Committee [2019]181.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval status"}}],"article-number":"11158"}}